• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    More On VRX.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Valeant Pharmaceuticals International, Inc. (VRX.TO)

    -Toronto
    122.69 Up 6.33(5.44%) Feb 12, 3:59PM EST
    Prev Close:116.36
    Open:118.80
    Bid:122.40
    Ask:122.70
    1y Target Est:N/A
    Beta:0.618588
    Earnings Date:Feb 22 - Feb 26 (Est.)
    Day's Range:118.79 - 123.08
    52wk Range:92.65 - 347.84
    Volume:577,386
    Avg Vol (3m):610,427
    Market Cap:42.10B
    P/E (ttm):70.47
    EPS (ttm):1.74
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Key Statistics

    Forward P/E (1 yr):9.10
    P/S (ttm):4.00
    Ex-Dividend Date:10-Nov-10

    Analysts

    Annual EPS Est (Dec-15) :10.27
    Quarterly EPS Est (Dec-15) :2.61
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):0.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback